FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Comparison of oral esomeprazole and oral omeprazole in the t...
Equine veterinary journal2023; doi: 10.1111/evj.13997

Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease.

Abstract: Oral omeprazole is the accepted treatment for equine squamous gastric disease (ESGD); however, it is not universally effective. Esomeprazole results in more consistent and pronounced acid suppression in men and is more effective than omeprazole in the treatment of oesophageal and gastric disease. Pharmacodynamic and pilot clinical studies have indicated esomeprazole might also be more effective than omeprazole in horses. Objective: To compare the efficacy and safety of oral esomeprazole and omeprazole pastes in the treatment of ESGD and, where present, concurrent equine glandular gastric disease (EGGD). Methods: Randomised, single-blinded controlled trial. Methods: Horses presenting with grade ≥2 ESGD lesions were randomly allocated to receive 4 mg/kg of either a buffered esomeprazole or omeprazole paste orally once daily for 28 days before gastroscopy being repeated within a further 3 days. Videos and images were anonymised and subsequently graded blind by one researcher. The severity of ESGD (and EGGD) lesions before and after treatment, and thereby treatment responses, were compared using univariable logistic regression. Results: A higher proportion of horses had ESGD healing in response to esomeprazole treatment (63/74, 85%) than with omeprazole treatment (43/73, 59%) (odds ratio [OR]: 4.00, 95% confidence interval [CI]: 1.81, 8.82, p = 0.001). In a subset of horses that had concurrent EGGD, a greater proportion of the horses treated with esomeprazole had lesions ≤grade 1 (esomeprazole 28/51, 55%; omeprazole 6/24, 25%; OR: 3.65, 95% CI: 1.25, 10.71, p = 0.02) Using grade 0 as the benchmark for EGGD healing, the difference remained significant (OR: 4.44, 95% CI: 1.33, 14.85, p = 0.02). Conclusions: It may not be possible to extrapolate these results to other populations with different signalment or management. Conclusions: Oral-buffered esomeprazole was a more effective treatment for ESGD (and concurrent EGGD) than oral-buffered omeprazole. Unassigned: Oral verabreichtes Omeprazol ist die akzeptierte Behandlungsform von Equine Squamous Gastric Disease (ESGD); allerdings ist es nicht universell effektiv. Esomeprazol resultiert in konsistenterer und ausgeprägter Säuresuppression beim Menschen und ist effektiver als Omeprazol in der Behandlung von Ösophageal- und Magenerkrankungen. Pharmakodynamische und klinische Pilotstudien ließen erkennen, dass Esomeprazol auch bei der Behandlung von Pferden effektiver ist als Omeprazol. Unassigned: Vergleich der Effektivität und Sicherheit oraler Esomeprazol- und Omeprazolpasten bei der Behandlung ESGD, und, falls vorhanden, zeitgleich auftretendem Equine Glandular Gastric Disease (EGGD). Methods: Randomisierte, einfach verblindete Fallkontrollstudie. Methods: Pferde mit Grad ≥2 ESGD Läsionen wurden zufällig einer Behandlung mit 4 mg/kg gepufferter Esomeprazol- oder Omeprazolpaste zugewiesen, oral verabreicht SID für 28 Tage bevor eine Gastroscopie innerhalb weiterer 3 Tage wiederholt wurde. Videos und Bilder wurden anonymisiert und anschließend von einem geblendeten Autor gradiert. Der Schweregrad der ESGD (und EGGD) Läsionen vor und nach Behandlung, und damit Ansprechen auf die Behandlung, wurden mithilfe der univariablen logistischen Regression verglichen. Unassigned: Ein größerer Anteil an Pferden zeigte ESGD-Abheilung als Reaktion auf die Behandlung mit Esomeprazol (63/74, 85%) im Vergleich zu der Behandlung mit Omeprazol (43/73, 59%; OR:4.00, 95%CI:1.81, 8.82, p = 0.001). Ein größerer Anteil einer Teilmenge der Pferde mit simultanem EGGD, welche mit Esomeprazol behandelt wurden, hatte Läsionen ≤ Grad 1 (Esomeprazol 28/51, 55%; Omeprazol 6/24, 25%; OR: 3.65, 95%CI: 1.25, 10.71, p = 0.02). Wenn Grad 0 als Bezugsgröße für EGGD-Abheilung verwendet wurde, blieb der Unterschied signifikant (OR: 4.44, 95%CI: 1.33, 14.85, p = 0.02). HAUPTEINSCHRÄNKUNGEN: Es ist möglicherweise nicht möglich, diese Resultate auf andere Populationen mit abweichendem Signalement oder Management zu extrapolieren. Unassigned: Die orale Verabreichung von gepuffertem Esomeprazol war effektiver für die Behandlung von ESGD (und zeitgleich auftretendem EGGD) als die orale Verabreichung von gepuffertem Omeprazol.
© 2023 The Authors. Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2023-09-07 PubMed ID: 37678812DOI: 10.1111/evj.13997Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study reveals that oral-buffered esomeprazole is more effective than oral-buffered omeprazole in the treatment of equine squamous gastric disease (ESGD) and concurrent equine glandular gastric disease (EGGD).

Research Objectives and Methods

  • This research aimed to compare the efficacy and safety of esomeprazole and omeprazole pastes in treating ESGD and, when present, concurrent EGGD. Both drugs are used in treating gastric diseases, but esomeprazole has shown more consistent, pronounced effects on acid suppression. Therefore, the study hypothesized that esomeprazole might be more effective in horses too.
  • The method involved a randomized and single-blinded controlled trial. Horses with grade ≥2 ESGD lesions were treated with either a buffered esomeprazole or omeprazole paste, orally once daily for 28 days. Gastroscopy was then repeated within three days of the treatment. Treatment responses were compared using univariable logistic regression.

Research Findings

  • The study found that a higher proportion of horses had ESGD healing when treated with esomeprazole (85%) than with omeprazole (59%).
  • When EGGD was concurrently present, there was a greater proportion of horses treated with esomeprazole that showed lesions ≤grade 1 (55%) when compared to omeprazole-treated ones (25%), signifying a better healing response with esomeprazole.
  • When grade 0 was considered as the benchmark for EGGD healing, the difference in treatments remained significant, with esomeprazole treated horses faring better.

Conclusion and Implications of the Study

  • The results showed oral-buffered esomeprazole to be a more effective treatment option for ESGD and concurrent EGGD in horses, compared to oral-buffered omeprazole. This could change the approaches to treating these conditions, rendering better health outcomes for horses.
  • However, the study indicates the results may not be applicable or extrapolated to other populations due to difference in signalment or management. This implies that it’s necessary to take into account the specific circumstances and characteristics of other populations in subsequent studies or clinical application.

Cite This Article

APA
Sundra T, Gough S, Rossi G, Kelty E, Rendle D. (2023). Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease. Equine Vet J. https://doi.org/10.1111/evj.13997

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Sundra, Tania
  • Avon Ridge Equine Veterinary Services, Brigadoon, Western Australia, Australia.
Gough, Sarah
  • Hunter Equine Centre, Scone, New South Wales, Australia.
Rossi, Gabriele
  • School of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia, Australia.
Kelty, Erin
  • School of Population and Global Health, The University of Western Australia, Crawley, Western Australia, Australia.
Rendle, David
  • EMT Consulting, Devon, UK.

Grant Funding

  • Luoda Pharma

References

This article includes 36 references
  1. Sykes BW, Hewetson M, Hepburn RJ, Luthersson N, Tamzali Y. European College of Equine Internal Medicine Consensus Statement-equine gastric ulcer syndrome in adult horses.. J Vet Intern Med 2015;29(5):1288-1299.
  2. Lorenzo-Figueras M, Merritt AM. Effects of exercise on gastric volume and pH in the proximal portion of the stomach of horses.. Am J Vet Res 2002;63(11):1481-1487.
  3. Sykes BW. Courses for horses: rethinking the use of proton pump inhibitors in the treatment of equine gastric ulcer syndrome.. Equine Vet Educ 2019;31(8):441-446.
  4. Andrews FM, Sifferman RL, Bernard W, Hughes FE, Holste JE, Daurio CP. Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses.. Equine Vet J 1999;31(S29):81-86.
  5. Murray MJ, Haven ML, Eichorn ES, Zhang D, Eagleson J, Hickey GJ. Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses.. Equine Vet J 1997;29(6):425-429.
  6. Doucet MY, Vrins AA, Dionne R, Alva R, Ericsson G. Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.. Can Vet J 2003;44(7):581-585.
  7. Lester GD, Smith RL, Robertson ID. Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing thoroughbreds.. J Am Vet Med Assoc 2005;227(10):1636-1639.
  8. MacAllister CG, Sifferman RL, McClure SR, White GW, Vatistas NJ, Holste JE. Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial.. Equine Vet J 1999;31(S29):77-80.
  9. Gough S, Hallowell G, Rendle D. A study investigating the treatment of equine squamous gastric disease with long-acting injectable or oral omeprazole.. Vet Med Sci 2020;6(2):235-241.
  10. Sykes BW, Jokisalo JM. Rethinking equine gastric ulcer syndrome: part 2-equine squamous gastric ulcer syndrome (ESGUS).. Equine Vet Educ 2015;27(5):264-268.
  11. Thompson A. Monitoring the growing use of esomeprazole.. Prescriber 2019;30(4):37-39.
  12. Andersson T, Rohss K, Bredberg E, Hassan-Alin M. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.. Aliment Pharm Therap 2001;15(10):1563-1569.
  13. Lind T, Kyleback A, Rydberg L, Jonsson A, Andersson T, Hasselgren G. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of GERD.. Gastroenterology 2000;118(4):A18.
  14. Rohss K, Wildersmith C, Claarnilsson C, Lundin C, Hasselgren G. Esomeprazole 40 Mg provides more effective acid control than standard doses of all other proton pump inhibitors.. Gastroenterology 2001;120(5):A419.
  15. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man.. Gut 1983;24(4):270-276.
  16. Kendall MJ. Esomeprazole-the first proton pump inhibitor to be developed as an isomer.. Aliment Pharmacol Ther 2003;17:1-4.
  17. Bell NJV, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease.. Digestion 1992;51(S1):59-67.
  18. Wildersmith C. Esomeprazole 40 mg provides faster and more effective acid control than rabeprazole 20 mg in patients with symptoms of GERD.. Am J Gastroenterol 2001;96(9):S45.
  19. Pereira MC, Levy FL, Valadão CAA, Ferraz GC, Queiroz-Neto A. Preliminary study of the gastric acidity in thoroughbred horses at rest after enteral administration of esomeprazole magnesium (Nexium).. J Equine Vet Sci 2009;29(11):791-794.
  20. Huxford K, Dart A, Perkins N, Bell R, Jeffcott L. A pilot study comparing the effect of orally administered esomeprazole and omeprazole on gastric fluid pH in horses.. N Z Vet J 2017;65(6):318-321.
  21. Sykes BW, Underwood C, Mills PC. The effects of dose and diet on the pharmacodynamics of esomeprazole in the horse.. Equine Vet J 2017;49(5):637-642.
  22. Rendle DI. Oral esomeprazole as a treatment for equine gastric ulcer syndrome refractory to oral omeprazole.. Equine Vet J 2017;49(S51):25-26.
  23. Gough S, Hallowell G, Rendle D. Evaluation of the treatment of equine glandular gastric disease with either long-acting-injectable or oral omeprazole.. Vet Med Sci 2022;8(2):561-567.
  24. Sykes BW, Sykes KM, Hallowell GD. A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, dose-response clinical trial.. Equine Vet J 2013;47(3):285-290.
  25. . Recommendations for the diagnosis and treatment of equine gastric ulcer syndrome (EGUS): the equine gastric ulcer council.. Equine Vet Educ 1999;11(5):262-272.
  26. Rendle D, Bowen M, Brazil T, Conwell R, Hallowell G, Hepburn R. Recommendations for the management of equine glandular gastric disease.. UK-Vet Equine 2018;2(S1):2-11.
  27. Crumpton S, Baiker K, Hallowell G, Habershon-Butcher J, Bowen I. Diagnostic value of gastric mucosal biopsies in horses with glandular disease: abstracts.. Equine Vet J 2015;47(S48):9.
  28. Sykes BW, Sykes KM, Hallowell GD. A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.. Equine Vet J 2013;46(4):416-421.
  29. Sykes BW, Underwood C, Greer R, McGowan CM, Mills PC. The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.. Equine Vet J 2017;49(4):525-531.
  30. Sykes BW, Underwood C, McGowan CM, Mills PC. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.. J Vet Pharmacol Ther 2015;38(2):130-136.
  31. Sykes BW, Kathawala K, Song Y, Garg S, Page SW, Underwood C. Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse.. Equine Vet J 2017;49(6):795-801.
  32. Sykes BW, Sykes KM, Hallowell GD. A comparison between pre- and post exercise administration of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial: pre- vs. post exercise omeprazole for equine gastric ulcer syndrome.. Equine Vet J 2013;46(4):422-426.
  33. Rendle D. Treatment of equine glandular gastric disease in elite endurance horses with oral and long-acting injectable omeprazole: a randomised, blinded clinical trial (abstract).. Proceedings of the European College of Equine Internal Medicine Congress 2020.
  34. Sundra T. Esomeprazole in the treatment of equine glandular gastric disease.. UK-Vet Equine 2021;5(5):216-219.
  35. Sykes BW, Underwood C, Greer R, McGowan CM, Mills PC. Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse.. J Vet Pharmacol Ther 2016;39(1):78-83.
  36. Birkmann K, Junge HK, Maischberger E, Eser MW, Schwarzwald CC. Efficacy of omeprazole powder paste or enteric-coated formulation in healing of gastric ulcers in horses.. J Vet Intern Med 2014;28(3):925-933.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.